Detection of Anaplastic Lymphoma Kinase (ALK) Gene Rearrangement in Non-Small Cell Lung Cancer and Related Issues in ALK Inhibitor Therapy: A Literature Review

Author： Yi Eunhee S.  

Publisher： Adis International

ISSN： 1177-1062

Source： Molecular Diagnosis & Therapy, Vol.16, Iss.3, 2012-06, pp. : 143-150

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Anaplastic lymphoma kinase gene rearrangements in cytological samples of non–small cell lung cancer: Comparison with histological assessment

By  

CANCER CYTOPATHOLOGY, Vol. 122, Iss. 6, 2014-06 ,pp. : 445-453

John Wiley & Sons Inc

Access to resources Recommend Favorite

EML4-ALK Rearrangement and Its Clinical Significance in Chinese Patients with Advanced Non-Small Cell Lung Cancer

By  

Oncology, Vol. 83, Iss. 5, 2012-09 ,pp. : 248-256

Karger

Access to resources Recommend Favorite

Drug‐induced reduction in estimated glomerular filtration rate in patients with ALK‐positive non‐small cell lung cancer treated with the ALK inhibitor crizotinib

By  

CANCER, Vol. 120, Iss. 5, 2014-03 ,pp. : 664-674

John Wiley & Sons Inc

Access to resources Recommend Favorite

Alectinib-Induced Alopecia in a Patient with Anaplastic Lymphoma Kinase-Positive Non-Small Cell Lung Cancer

By  

Case Reports in Oncology, Vol. 9, Iss. 1, 2016-04 ,pp. : 212-215

Karger

Access to resources Recommend Favorite

Native and rearranged ALK copy number and rearranged cell count in non–small cell lung cancer

By  

CANCER, Vol. 119, Iss. 22, 2013-11 ,pp. : 3968-3975

John Wiley & Sons Inc

Access to resources Recommend Favorite